PR
Perrigo
PRGO · NYSE
$14.59 -2.21% (-$0.33)
1M +15.35%
Market Cap $2.02B
P/E Ratio -
Div. Yield 7.95%
ROE 55.97%
Bulios Fair Price
$10.59
27.4% downside
Trenutna cena
$14.59
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PRGO trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/S 0.49x
P/B 0.80x
P/FCF 11.54x
Growth
6 /100
Declining Rev. growth 1.51%
FCF growth 11.72%
Book val. growth 15.37%
Profitability
29 /100
Weak Gross margin 33.26%
Net margin 41.85%
Op. margin 5.19%
Quality
13 /100
Poor ROIC 3.46%
ROE 55.97%
ROA 22.80%
Debt
42 /100
Moderate Debt/Equity 1.31x
Current ratio 2.32x
Int. coverage -8.89x
Stability
52 /100
Moderate Beta 0.54x
Rev. volatility 5.45%
EPS volatility 666.62%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PRGO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Albert A. Manzone
Employees
8,100
Headquarters
Dublin
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report